MyFinsight
Home
Blog
About
Contact
abos: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$5,544K
Marketable securities,
short-term
$79,777K
Cash and cash
equivalents
$46,832K
Other assets,
long-term
$393K
Restricted cash
$232K
Marketable securities,
long-term
$9,443K
Total current assets
$132,153K
Total assets
$142,221K
Total liabilities and
stockholders equity
$142,221K
Total stockholders
equity
$93,173K
Total liabilities
$49,048K
Accumulated deficit
-$421,324K
Accumulated other
comprehensive income (loss)
$109K
Additional paid-in capital
$514,382K
Other liabilities,
long-term
$39K
Debt, long-term
$27,053K
Total current
liabilities
$21,956K
Common stock, 0.0001
par value...
$6K
Debt, short-term
$3,598K
Accrued expenses and
other current...
$7,792K
Accrued clinical trial
expenses
$9,884K
Accounts payable
$682K
Back
Back
Balance Sheet
source: myfinsight.com
Acumen Pharmaceuticals, Inc. (ABOS)
Acumen Pharmaceuticals, Inc. (ABOS)